A Comparative Study of Rupatadine 10 mg Tablets and Clarinex® 5 mg Tablets Under Fasting Conditions
Clinical trial NCT05356143 · COMPLETED
Trial details
- NCT number
- NCT05356143
- Sponsor
- J. Uriach and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2022-01-13
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.